Evotec, GSK, J&J, Otsuka, Gates MRI & Gates Foundation launch consortium to develop new pan-TB drug
A consortium of philanthropic, non-profit and private sector organisations launched a collaboration that aims to accelerate the development of novel “pan-TB” drug... Read More
Nestlé, Valbiotis partners to develop & commercialize plant-derived active substance, TOTUM-63 to reduce risk of developing type 2 diabetes
Posted on09 Feb 2020
Comments0
Nestlé Health Science and Valbiotis, a research and development company committed to scientific innovation for preventing and combating metabolic diseases, have entered... Read More
CODA Biotherapeutics acquired 3 clinical stage assets from Attenua
CODA Biotherapeutics, a preclinical-stage biopharmaceutical company developing a gene therapy-mediated chemogenetic platform, announced it has completed the acquisition of Attenua, Inc. With... Read More
Insight on Alteogen’s non-exclusive licensing deal for ALT-B4 to a top 10 global pharma
South Korean company Alteogen Inc. signed a nonexclusive global license agreement with a top 10 global pharmaceutical company for its recombinant human... Read More
Pharma Strategic Deal: Astellas Pharma to acquire Audentes Therapeutics for about $3 billion
Posted on05 Dec 2019
TagsAstellas, Astellas Pharma, biopharma business development, Pharma Business Development, pharma strategic deal
Comments0
Astellas Pharma Inc. anannounced that they have entered into a definitive agreement for Astellas to acquire Audentes at a price of US$60.00... Read More
Pharma Business Development – Competency Test. Check your competency
Pharma Business Development – Competency Test. Check your competency